CIK 0000748592 · Non-accelerated filer<br>Smaller reporting company
Ernexa Therapeutics Inc.
Sign in to watch- Ticker
- ERNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 311103425
- Phone
- (617) 798-6700
- Business address
- 1035 CAMBRIDGE STREET, SUITE 18A, CAMBRIDGE, MA, 02141
- Former names
- Eterna Therapeutics Inc., Brooklyn ImmunoTherapeutics, Inc., NTN BUZZTIME INC, NTN COMMUNICATIONS INC
Securities
- ERNA Common Stock Nasdaq
- ERNAW Warrants Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 89 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2009-06-26 | Bateman Terry Allan CEO | Option exercise | +145,833 | $0.17 | $25K | 145,833 |
| 2009-06-26 | Bateman Terry Allan CEO | Option exercise | +30,000 | $0.12 | $4K | 175,833 |
| 2009-06-26 | Bateman Terry Allan CEO | Option exercise · Employee Stock Option (Right to Buy | −145,833 | 1,604,167 | ||
| 2009-06-26 | Bateman Terry Allan CEO | Option exercise · Employee Stock Option (Right to Buy) | −30,000 | 0 | ||
| 2009-06-18 | Glassman Nicholas A EVP of Product and Technology | Purchase | +10,000 | $0.47 | $5K | 10,000 |
| 2009-06-15 | Farricielli Joseph J. Jr. Director | Purchase | +10,000 | $0.42 | $4K | 110,000 |
| 2009-06-10 | Keymer Kenneth L Director | Purchase | +20,000 | $0.40 | $8K | 70,000 |
| 2009-06-10 | Keymer Kenneth L Director | Purchase | +20,000 | $0.40 | $8K | 90,000 |
| 2009-06-10 | Keymer Kenneth L Director | Purchase | +8,100 | $0.40 | $3K | 98,100 |
| 2009-06-09 | Keymer Kenneth L Director | Purchase | +9,900 | $0.40 | $4K | 49,900 |
| 2009-06-09 | Keymer Kenneth L Director | Purchase | +19,900 | $0.40 | $8K | 20,000 |
| 2009-06-09 | Keymer Kenneth L Director | Purchase | +20,000 | $0.40 | $8K | 40,000 |
| 2009-06-09 | Keymer Kenneth L Director | Purchase | −9,900 | $0.40 | $4K | 49,900 |
| 2009-06-09 | Keymer Kenneth L Director | Purchase | +100 | $0.39 | $39 | 50,000 |
| 2009-06-08 | Keymer Kenneth L Director | Purchase | +100 | $0.40 | $40 | 100 |
| 2009-06-04 | Farricielli Joseph J. Jr. Director | Purchase | +1,300 | $0.41 | $533 | 100,000 |
| 2009-06-01 | Farricielli Joseph J. Jr. Director | Purchase | +2,700 | $0.36 | $972 | 98,700 |
| 2009-05-22 | Lewis Mary Beth Director | Purchase | +10,000 | $0.40 | $4K | 10,000 |
| 2009-05-19 | Farricielli Joseph J. Jr. Director | Purchase | +20,000 | $0.39 | $8K | 96,000 |
| 2009-05-15 | Trinad Capital Master Fund Ltd. 10% owner | Purchase | +50,000 | $0.39 | $19K | 8,900,093 |
Page 29 of 33 · 657 trades